Company intelligence / Profile preview

MyOme

Menlo Park, California, USAmyome.com ↗

Ownership: Private
Development stage: Commercial

Overview

MyOme has launched commercial clinical-grade whole genome sequencing-based tests for both proactive health screening and rare disease diagnostics. Their polygenic risk scores have been validated across diverse ancestries. The company recently launched its rare disease diagnostic portfolio at ACMG 2025. They have published data in peer-reviewed journals such as Nature Medicine demonstrating the utility of their PRS technology in various indications including cancer, cardiac, metabolic, and autoimmune diseases. Clinical studies show improved cross-population performance for breast cancer PRS.

Therapeutic areas: OncologyCardiovascularRare DiseasesEndocrinology
Modalities: Diagnostic testGenomic analysisPolygenic risk score (PRS)Whole genome sequencing (WGS)
Industry: Molecular Diagnostics

Partnerships

Novi Health – strategic partnership to deliver WGS-based testing as part of employer health benefits programs.

Beyond the preview

Go deeper on MyOme.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MyOme.

Explore the full profile